These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 111311)

  • 1. The protective effect of non-immunologic granulomatous inflammation in Trypanosoma cruzi infection of mice.
    De Mesquita RP
    Rev Bras Biol; 1979 Mar; 39(1):99-102. PubMed ID: 111311
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity.
    Paiva CN; Arras RH; Lessa LP; Gibaldi D; Alves L; Metz CN; Gazzinelli R; Pyrrho AS; Lannes-Vieira J; Bozza MT
    Eur J Immunol; 2007 May; 37(5):1355-64. PubMed ID: 17390393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagas cardiomyopathy (Trypanosoma cruzi): does prolactin play a role?
    Pearson RD
    Cytokine Growth Factor Rev; 2007; 18(3-4):209. PubMed ID: 17512239
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
    Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S
    Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
    Campos MA; Gazzinelli RT
    Mediators Inflamm; 2004 Jun; 13(3):139-43. PubMed ID: 15223603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats.
    Melo RC; Machado CR
    Exp Parasitol; 2001 Jan; 97(1):15-23. PubMed ID: 11207110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the age of a rat on the course of infection with Trypanosoma cruzi].
    Revelli S; Moreno H; Berra H; Valenti JL; Lía Nocito A; Amerio N; Morini JC
    Medicina (B Aires); 1987; 47(4):360-6. PubMed ID: 3133534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of macrophages in the genetic control of the susceptibility and resistance to experimental infection by Trypanosoma cruzi (proceedings)].
    Pécora IL; Barcinski MA; Gaspar MI
    An Acad Bras Cienc; 1978 Sep; 50(3):430. PubMed ID: 103472
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of acute infection by Trypanosoma cruzi upon the response of mice to sheep erythrocytes.
    Schmuñis GA; Szarfman A; Pesce UJ; González-Cappa SM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):323-31. PubMed ID: 416482
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi.
    Wirth JJ; Kierszenbaum F
    J Immunol; 1985 Mar; 134(3):1989-93. PubMed ID: 2857187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi.
    Ropert C; Gazzinelli RT
    J Endotoxin Res; 2004; 10(6):425-30. PubMed ID: 15588426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denervation and the immune response in mice infected with Trypanosoma cruzi.
    Ribeiro dos Santos ; Hudson L
    Clin Exp Immunol; 1981 May; 44(2):349-54. PubMed ID: 6796312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
    J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.